Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.

scientific article published on 27 November 2006

Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/511144
P698PubMed publication ID17143809
P5875ResearchGate publication ID6654845

P50authorMyron S. CohenQ16733099
William C. MillerQ30507980
Jane R SchwebkeQ97118155
Julius AtashiliQ115147099
Peter A. LeoneQ121075428
Heidi SwygardQ125217147
P2093author name stringMarcia M Hobbs
Arlene C Seña
P2860cites workTrichomoniasis in men and HIV infection: data from 2 outpatient clinics at Lilongwe Central Hospital, MalawiQ30960781
The infrequent use of office-based diagnostic tests for vaginitisQ33690613
Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimensQ33824751
Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in womenQ33947022
Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimensQ33973382
Improved detection by DNA amplification of Trichomonas vaginalis in malesQ34200955
Trichomoniasis: under control or undercontrolled?Q34293435
Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men.Q34748499
Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasisQ35220782
Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventionsQ35528767
Laboratory tests used in US public health laboratories for sexually transmitted diseases, 2000.Q35755519
The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatmentQ36955440
High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis managementQ37868981
Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virusQ37872788
Predictors of the vaginal microfloraQ37874418
Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinicQ37876647
Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalisQ37879288
Rates of and risk factors for trichomoniasis among pregnant inmates in New York CityQ37880630
Risk assessment and laboratory diagnosis of trichomoniasis in men.Q37892133
Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies.Q38570406
Genital Ulcers Associated with Human Immunodeficiency Virus-Related Immunosuppression in Female Sex Workers in Abidjan, Ivory CoastQ45788322
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study GroupQ47305969
The prevalence of trichomoniasis in young adults in the United States.Q54638256
Trichomonas vaginalis--no longer a minor STD.Q55033250
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectsexually transmitted infectionQ12198
Trichomonas vaginalisQ132595
preventionQ1717246
P304page(s)13-22
P577publication date2006-11-27
P1433published inClinical Infectious DiseasesQ5133764
P1476titleTrichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
P478volume44

Reverse relations

cites work (P2860)
Q36311615A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections
Q98166342A Systematic Review of the Literature on Mechanisms of 5-Nitroimidazole Resistance in Trichomonas vaginalis
Q37641408Can trichomoniasis cause pharyngitis? A case report.
Q49579805Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (abridged version).
Q49579785Canadian Urological Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version).
Q26778560Clinical and Laboratory Testing for Trichomonas vaginalis Infection
Q36871544Comparative analysis of syndromic and PCR-based diagnostic assay reveals misdiagnosis/ overtreatment for trichomoniasis based on subjective judgment in symptomatic patients
Q64101932Comparison of Seropositivity to Trichomonas vaginalis between Men with Prostatic Tumor and Normal Men
Q40304979Correlates of Trichomonas vaginalis Among Middle Age and Older Adults Who Use Drugs.
Q37855843Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
Q37050952Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans
Q42252382Current status and prospects for development of a vaccine against Trichomonas vaginalis infections
Q36142110Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia.
Q58835870Diagnosing Vaginal Infections: It’s Time to Join the 21st Century
Q37374876Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women
Q58835994Editorial Commentary: Trichomonas vaginalisInfection: The Most Prevalent Nonviral Sexually Transmitted Infection Receives the Least Public Health Attention
Q37270533Epidemiology and treatment of trichomoniasis
Q35880422Genital infections and syndromic diagnosis among HIV-infected women in HIV care programmes in Kenya
Q37497330Ginger (Zingiber officinale) induces apoptosis in Trichomonas vaginalis in vitro
Q38112673Global epidemiology of Trichomonas vaginalis
Q42740170Gonorrhoea & its co-infection with other ulcerative, non-ulcerative sexually transmitted & HIV infection in a Regional STD Centre
Q38247206Immunity in urogenital protozoa
Q37456846Impact of T. vaginalis infection on innate immune responses and reproductive outcome
Q36911891Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis
Q38797613Inflammatory response of a prostate stromal cell line induced by Trichomonas vaginalis
Q39043131Inflammatory response of prostate epithelial cells to stimulation by Trichomonas vaginalis
Q38128845Insights into trichomoniasis as a result of highly sensitive molecular diagnostics screening in a high-prevalence sexually transmitted infection community
Q33745589Interaction between Trichomonas vaginalis and the Prostate Epithelium.
Q35276050Internet-based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men
Q36105015Leukocyte Lysis and Cytokine Induction by the Human Sexually Transmitted Parasite Trichomonas vaginalis
Q37119274Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention
Q35220782Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis
Q36180027Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care
Q26822739Modern diagnosis of Trichomonas vaginalis infection
Q38382893Natural and synthetic compound anti-Trichomonas vaginalis: an update review
Q33588454Neglected parasitic infections in the United States: trichomoniasis
Q30239882Nonviral sexually transmitted infections-epidemiology, clinical manifestations, diagnostic workup, therapy : Part 3: Treponemes, Gardnerella and trichomonads
Q36032897PCR for diagnosis of male Trichomonas vaginalis infection with chronic prostatitis and urethritis
Q37550276Prevalence and Correlates of Genital Infections Among Newly Diagnosed Human Immunodeficiency Virus-Infected Adults Entering Human Immunodeficiency Virus Care in Windhoek, Namibia
Q40068325Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia
Q34411072Prevalence of Trichomonas vaginalis by PCR in men attending a primary care urology clinic in South Korea
Q41921303Prevalence of Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional study
Q34019287Prevalence of Trichomonas vaginalis infection in Kashan city, Iran (2012-2013)
Q36911870Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea
Q36880250Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men.
Q90235676Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana
Q37834503Prevention of Sexually Transmitted Diseases in HIV-Infected Individuals
Q39136758Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell
Q24650442Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study
Q90470116Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection
Q84952075Refractory Trichomoniasis in HIV-positive and HIV-negative Subjects
Q33696455Regulation of gene expression in protozoa parasites
Q55717765Review of Trichomonas vaginalis in Iran, Based on Epidemiological Situation.
Q34479272Sexually transmitted diseases treatment guidelines, 2015.
Q36998820Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
Q38736205Signalling pathways associated with IL-6 production and epithelial-mesenchymal transition induction in prostate epithelial cells stimulated with Trichomonas vaginalis
Q50028228Susceptibility of clinical isolates of Trichomonas vaginalis to metronidazole and secnidazole-an in vitro study
Q37214609The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis
Q35836824The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya
Q37456656The male sexual partners of adult versus teen women with sexually transmitted infections
Q51109089The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.
Q48613148Therapeutic effects of Iranian herbal extracts against Trichomonas vaginalis
Q55473211Therapeutic effects of Iranian herbal extracts against Trichomonas vaginalis.
Q55363854Trichomonas vaginalis Induces Production of Proinflammatory Cytokines in Mouse Macrophages Through Activation of MAPK and NF-κB Pathways Partially Mediated by TLR2.
Q36826973Trichomonas vaginalis contact-dependent cytolysis of epithelial cells
Q90639070Trichomonas vaginalis extracellular vesicles are internalized by host cells using proteoglycans and caveolin-dependent endocytosis
Q36368342Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence
Q30358403Trichomonas vaginalis screening and prevention in order to impact the HIV pandemic: Isn't it time we take this infection seriously?
Q27025282Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues
Q38627476Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure
Q34173528Trichomoniasis: evaluation to execution
Q34387759Trichomoniasis: the "neglected" sexually transmitted disease

Search more.